Synthetic peptide dKn2-7 loaded into calcium alginate wound dressing fibers achieved 99% reduction in Candida albicans biofilms on porcine skin with no significant tissue damage, offering a promising antifungal wound care strategy.
99% biofilm reductiondKn2-7-loaded alginate fibers eliminated Candida biofilms on porcine skin at 500 µg/mg loading with no tissue damage
What the researchers found
dKn2-7-loaded alginate fibers achieved 99% reduction in Candida albicans biofilms on ex vivo porcine skin at 500 µg/mg loading, with no significant tissue damage and preserved hemostatic function.
Why it matters
Fungal wound infections are increasingly common and difficult to treat, especially in immunocompromised patients. A wound dressing that simultaneously provides hemostasis, wound healing support, and sustained antifungal peptide delivery could address a critical unmet clinical need.
The numbers in context
The dressing uses dKn2-7, a synthetic antifungal peptide, incorporated into calcium alginate microfibers for extended release.
How the study worked
In vitro and ex vivo study: dKn2-7 loaded into calcium alginate microfibers at varying concentrations. Characterized release kinetics, calcium release, planktonic and biofilm killing (in vitro), and biofilm reduction on porcine skin (ex vivo). Histological assessment for tissue damage.
Who was studied
Candida albicans cultures and ex vivo tissue models
What this study cannot tell us
Ex vivo porcine skin model — not tested in live wounds. The burst release profile may not provide sustained antifungal coverage beyond 24 hours. Only tested against C. albicans — other fungal pathogens may respond differently. Manufacturing scalability not addressed.
How to read the evidence
Preliminary evidence from in vitro and ex vivo studies. Promising results but requires in vivo wound model validation.
When this study was published
Published in 2024. Advances peptide-based antimicrobial wound dressing technology.
The bigger picture
Antimicrobial peptides in wound dressings represent a growing alternative to conventional antifungals. As drug resistance increases, having a peptide-based option that can be delivered locally via a wound dressing could become an essential tool in wound care.
Questions still open
- Would dKn2-7 fibers be effective against other pathogenic fungi (Aspergillus, Cryptococcus)?
- Can the release profile be modified to provide sustained antifungal activity beyond 24 hours?
- How do these dressings perform in animal wound infection models?
Common questions
What makes this wound dressing special?
Why use a peptide instead of regular antifungal drugs?
Read the original research
Antifungal peptide-loaded alginate microfiber wound dressing evaluated against Candida albicans in vitro and ex vivo.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 205, 114578
Citation
Snyder, Sabrina S; Rock, Crystal A; Millenbaugh, Nancy J. (2024). Antifungal peptide-loaded alginate microfiber wound dressing evaluated against Candida albicans in vitro and ex vivo.. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 205, 114578. https://doi.org/10.1016/j.ejpb.2024.114578